Human flavin monoxygenase 1 (FMO1) as a catalyst of nicotine N-Oxidation

被引：0
|
作者：
Murphy, Sharon E. [1 ]
von Weymarn, Linda B. [1 ]
Hinrichs, Anthony L. [2 ]
机构：
[1] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA
[2] Washington Univ, Dept Psychiat, St Louis, MO USA
来源：
DRUG METABOLISM REVIEWS | 2009年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
309
引用
收藏
页码：152 / 153
页数：2
相关论文
共 50 条
  • [21] The Arabidopsis flavin-dependent monooxygenase FMO1 is an essential component of biologically induced systemic acquired resistance
    Mishina, Tatiana E.
    Zeier, Juergen
    PLANT PHYSIOLOGY, 2006, 141 (04) : 1666 - 1675
  • [22] Structural characteristics of flavin-containing monooxygenase genes one and two (FMO1 and FM02)
    Wyatt, MK
    Philpot, RM
    Carver, G
    Lawton, MP
    Nikbakht, KN
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (12) : 1320 - 1327
  • [23] Induction of flavin-containing monooxygenase (FMO1) by a polycyclic aromatic hydrocarbon, 3-methylcholanthrene, in rat liver
    Chung, WG
    Park, CS
    Roh, HK
    Cha, YN
    MOLECULES AND CELLS, 1997, 7 (06) : 738 - 741
  • [24] Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes
    Henderson, Marilyn C.
    Siddens, Lisbeth K.
    Morre, Jeffrey T.
    Krueger, Sharon K.
    Williams, David E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2008, 233 (03) : 420 - 427
  • [25] DEFICIENT NICOTINE N-OXIDATION IN 2 SISTERS WITH TRIMETHYLAMINURIA
    AYESH, R
    ALWAIZ, M
    CROTHERS, MJ
    CHOLERTON, S
    MITCHELL, SC
    IDLE, JR
    SMITH, RL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (05) : P664 - P665
  • [26] Physiological factors affecting the expression of FMO1 and FMO3 in the rat liver and kidney
    Lattard, V
    Lachuer, J
    Buronfosse, T
    Garnier, F
    Benoit, E
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (08) : 1453 - 1464
  • [27] Flavin-containing monooxygenase-mediated N-oxidation of the M1-muscarinic agonist xanomeline
    Ring, BJ
    Wrighton, SA
    Aldridge, SLK
    Hansen, K
    Haehner, B
    Shipley, LA
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (10) : 1099 - 1103
  • [28] COPE ELIMINATION MEDIATED BY HUMAN FMO1 LEADS TO FORMATION OF REACTIVE MICHAEL ACCEPTOR INTERMEDIATE
    Lai, Weidong
    Siu, Amy
    Yu, Robert
    Moniz, George
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S58 - S58
  • [29] PROCHIRAL SULFOXIDATION AS A PROBE FOR MULTIPLE FORMS OF THE MICROSOMAL FLAVIN-CONTAINING MONOOXYGENASE - STUDIES WITH RABBIT FMO1, FMO2, FMO3, AND FMO5 EXPRESSED IN ESCHERICHIA-COLI
    RETTIE, AE
    LAWTON, MP
    SADEQUE, AJM
    MEIER, GP
    PHILPOT, RM
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 311 (02) : 369 - 377
  • [30] AN ASSAY OF FLAVIN-CONTAINING MONOOXYGENASE ACTIVITY WITH BENZYDAMINE N-OXIDATION
    KAWAJI, A
    OHARA, K
    TAKABATAKE, E
    ANALYTICAL BIOCHEMISTRY, 1993, 214 (02) : 409 - 412
12345